deferrioxamine e has been researched along with isoniazid in 1 studies
Studies (deferrioxamine e) | Trials (deferrioxamine e) | Recent Studies (post-2010) (deferrioxamine e) | Studies (isoniazid) | Trials (isoniazid) | Recent Studies (post-2010) (isoniazid) |
---|---|---|---|---|---|
25 | 0 | 17 | 21,815 | 960 | 4,493 |
Protein | Taxonomy | deferrioxamine e (IC50) | isoniazid (IC50) |
---|---|---|---|
Myeloperoxidase | Homo sapiens (human) | 4.85 | |
Enoyl-[acyl-carrier-protein] reductase [NADH] | Mycobacterium tuberculosis H37Rv | 8.29 | |
Putative FAD-containing monooxygenase MymA | Mycobacterium tuberculosis H37Rv | 4.9 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arai, M; Ishida, S; Kobayashi, M; Niikawa, H | 1 |
1 other study(ies) available for deferrioxamine e and isoniazid
Article | Year |
---|---|
Inhibitory effect of cyclic trihydroxamate siderophore, desferrioxamine E, on the biofilm formation of Mycobacterium species.
Topics: Actinobacteria; Anti-Bacterial Agents; Biofilms; Colony Count, Microbial; Drug Discovery; Drug Resistance, Bacterial; Hydroxamic Acids; Iron; Isoniazid; Lactams; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium bovis; Mycobacterium smegmatis; Siderophores | 2011 |